×
For best experience we recommend to activate Javascript in your browser.
SIGLEC7 antibody
This Mouse Monoclonal antibody specifically detects SIGLEC7 in FACS. It exhibits reactivity toward Human.
Quick Overview for SIGLEC7 antibody (ABIN2664582)
Target
See all SIGLEC7 Antibodies
SIGLEC7
(Sialic Acid Binding Ig-Like Lectin 7 (SIGLEC7))
Reactivity
All reactivities for SIGLEC7 antibodies
Human
Host
All hosts for SIGLEC7 antibodies
Mouse
Clonality
All clonalities for SIGLEC7 antibodies
Monoclonal
Conjugate
All conjugates for SIGLEC7 antibodies
This SIGLEC7 antibody is un-conjugated
Application
All applications for SIGLEC7 antibodies
Flow Cytometry (FACS)
Clone
S7-7
Product Details anti-SIGLEC7 Antibody
(hide)
Purification
The antibody was purified by affinity chromatography.
Isotype
IgG1 kappa
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Concentration
0.5 mg/mL
Buffer
Phosphate-buffered solution, pH 7.2, containing 0.09 % sodium azide.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C
Storage Comment
The antibody solution should be stored undiluted between 2°C and 8°C.
Target Details for SIGLEC7
(hide)
Target
SIGLEC7
(Sialic Acid Binding Ig-Like Lectin 7 (SIGLEC7))
Alternative Name
CD328
Background
Siglec-7 is a 75 kD type I transmembrane protein and a member of the family of sialic acid-binding immunoglobulin-like lectins (Siglecs), also known as p75/AIRM1. It is primarily found on NK cells and monocytes. The cytoplasmic domain of Siglec-7 contains immunoreceptor tyrosine-based inhibitory motif (ITIM). CD328 mediates sialic acid-dependent cell-cell binding and functions as an inhibitory receptor of NK cells. CD328 preferentially binds to sialylated glycans with α2,8 disialyl and α2,6 sialyl residues.
Recently viewed
(hide)
Chat with us , powered by LiveChat